Créer un compteSe connecter

Recherches récentes

Aucune recherche récente

Options de recherche

Disponible uniquement lorsque vous êtes connecté.
mastouille.fr est l'un des nombreux serveurs Mastodon indépendants que vous pouvez utiliser pour participer au fédiverse.
Mastouille est une instance Mastodon durable, ouverte, et hébergée en France.

Administré par :

Statistiques du serveur :

645
comptes actifs

mastouille.fr: À proposAnnuaire des profilsPolitique de confidentialité

Mastodon: À proposTélécharger l’applicationRaccourcis clavierVoir le code sourcev4.3.4

#ipscell

0 message0 participant0 message aujourd’hui
Alo Japan<p><a href="https://www.alojapan.com/1256575/ips-cell-research-can-give-japan-lead-in-regenerative-medicine/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">alojapan.com/1256575/ips-cell-</span><span class="invisible">research-can-give-japan-lead-in-regenerative-medicine/</span></a> iPS Cell Research Can Give Japan Lead in Regenerative Medicine <a href="https://channels.im/tags/Economy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Economy</span></a>&amp;Tech <a href="https://channels.im/tags/editorial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>editorial</span></a> <a href="https://channels.im/tags/editorials" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>editorials</span></a> <a href="https://channels.im/tags/IPSCell" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IPSCell</span></a> <a href="https://channels.im/tags/IpsCells" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IpsCells</span></a> <a href="https://channels.im/tags/Japan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Japan</span></a> <a href="https://channels.im/tags/JapanNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>JapanNews</span></a> <a href="https://channels.im/tags/JapanTopics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>JapanTopics</span></a> <a href="https://channels.im/tags/KyotoUniversity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>KyotoUniversity</span></a> <a href="https://channels.im/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>medicine</span></a> <a href="https://channels.im/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a> <a href="https://channels.im/tags/Parkinson" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Parkinson</span></a>'sDisease <a href="https://channels.im/tags/ShinyaYanaka" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ShinyaYanaka</span></a> The day when regenerative medicine using induced pluripotent stem cells (iPS cells) will be used in real-world treatments is fast approaching. For Japan to become a world leader in the field of iPS cell technologies, the gove…</p>
Alo Japan<p><a href="https://www.alojapan.com/1252970/pioneering-a-cure-for-parkinsons-disease-first-allogeneic-ips-cell-based-therapy-demonstrates-safety-and-efficacy%ef%bd%9cnews-events-cira/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">alojapan.com/1252970/pioneerin</span><span class="invisible">g-a-cure-for-parkinsons-disease-first-allogeneic-ips-cell-based-therapy-demonstrates-safety-and-efficacy%ef%bd%9cnews-events-cira/</span></a> Pioneering a Cure for Parkinson’s Disease: First Allogeneic iPS Cell-Based Therapy Demonstrates Safety and Efficacy｜News &amp; Events | CiRA <a href="https://channels.im/tags/CiRA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CiRA</span></a> <a href="https://channels.im/tags/iPS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>iPS</span></a> <a href="https://channels.im/tags/IPSCell" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IPSCell</span></a> <a href="https://channels.im/tags/Kyoto" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Kyoto</span></a> <a href="https://channels.im/tags/KyotoNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>KyotoNews</span></a> <a href="https://channels.im/tags/KyotoUniversity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>KyotoUniversity</span></a> <a href="https://channels.im/tags/news" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>news</span></a> <a href="https://channels.im/tags/StemCell" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StemCell</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>京都</span></a> <a href="https://channels.im/tags/%E4%BA%AC%E9%83%BD%E5%BA%9C" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>京都府</span></a> A team of researchers and clinicians from CiRA and Kyoto University Hospital, led by Professors Jun Takahashi (Department of Clinical Application) and Ryosuke Takahashi (Graduate School of Medicine), has set a new mile…</p>
ExplorerFlux en direct
À propos